Segui
Giovanna Malara
Giovanna Malara
GOM "BMM" Reggio Calabria
Email verificata su ospedalerc.it
Titolo
Citata da
Citata da
Anno
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study
C Patruno, M Napolitano, G Argenziano, K Peris, M Ortoncelli, ...
Journal of the European Academy of Dermatology and Venereology 35 (4), 958-964, 2021
812021
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis
MC Fargnoli, M Esposito, S Ferrucci, G Girolomoni, A Offidani, A Patrizi, ...
Journal of Dermatological Treatment 32 (5), 507-513, 2021
762021
An Italian multicentre study on adult atopic dermatitis: persistent versus adult-onset disease
M Megna, C Patruno, A Balato, F Rongioletti, L Stingeni, N Balato
Archives of dermatological research 309, 443-452, 2017
602017
IL12B (p40) gene polymorphisms contribute to ustekinumab response prediction in psoriasis
M Galluzzo, AN Boca, E Botti, C Potenza, G Malara, P Malagoli, S Vesa, ...
Dermatology 232 (2), 230-236, 2016
592016
Italian guidelines for therapy of atopic dermatitis—Adapted from consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis)
G Damiani, P Calzavara‐Pinton, L Stingeni, K Hansel, F Cusano, ...
Dermatologic Therapy 32 (6), e13121, 2019
572019
Secukinumab shows high efficacy irrespective of HLA‐Cw6 status in patients with moderate‐to‐severe plaque‐type psoriasis: SUPREME study
A Costanzo, L Bianchi, ML Flori, G Malara, L Stingeni, M Bartezaghi, ...
British journal of dermatology 179 (5), 1072-1080, 2018
572018
Prevalence of alexithymia in patients with psoriasis and its association with disease burden: a multicentre observational study
F Sampogna, L Puig, P Spuls, G Girolomoni, MA Radtke, B Kirby, ...
British Journal of Dermatology 176 (5), 1195-1203, 2017
572017
Treat-to-target approach for the management of patients with moderate-to-severe plaque psoriasis: consensus recommendations
P Gisondi, M Talamonti, A Chiricozzi, S Piaserico, P Amerio, A Balato, ...
Dermatology and Therapy 11, 235-252, 2021
482021
Photodynamic therapy of acne using methyl aminolaevulinate diluted to 4% together with low doses of red light
L Mavilia, G Malara, G Moretti, M Lo Re, AP Guerra
British Journal of Dermatology 157 (4), 810-811, 2007
482007
Italian expert consensus for the management of actinic keratosis in immunocompetent patients
K Peris, PG Calzavara‐Pinton, L Neri, G Girolomoni, G Malara, A Parodi, ...
Journal of the European Academy of Dermatology and Venereology 30 (7), 1077-1084, 2016
462016
C-reactive protein and markers for thrombophilia in patients with chronic plaque psoriasis
P Gisondi, M Malerba, G Malara, AP Guerra, R Sala, A Radaeli, ...
International journal of immunopathology and pharmacology 23 (4), 1195-1202, 2010
392010
Lymphocutaneous sporotrichosis in an immunocompetent patient: a case report from extreme southern Italy
G Criseo, G Malara, O Romeo, A Puglisi Guerra
Mycopathologia 166, 159-162, 2008
382008
Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience
A Conti, F Peccerillo, P Amerio, A Balato, F Bardazzi, L Bianchi, ...
British Journal of Dermatology 180 (6), 1547-1548, 2019
372019
HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa
K Peris, A Lo Schiavo, G Fabbrocini, V Dini, A Patrizi, M Fusano, L Bianchi, ...
Journal of the European Academy of Dermatology and Venereology 33 (4), 766-773, 2019
332019
Effectiveness end points in real-world studies on biological therapies in psoriasis: systematic review with focus on drug survival
A Costanzo, G Malara, C Pelucchi, F Fatiga, G Barbera, A Franchi, ...
Dermatology 234 (1-2), 1-12, 2018
332018
Consensus on the management of patients with psoriatic arthritis in a dermatology setting
P Gisondi, G Altomare, F Ayala, A Conti, P Dapavo, C De Simone, C Foti, ...
Journal of the European Academy of Dermatology and Venereology 32 (4), 515-528, 2018
332018
Secukinumab shows high efficacy irrespective of HLA‐Cw6 status in patients with moderate‐to‐severe plaque‐type psoriasis: results from extension phase of the …
M Papini, F Cusano, M Romanelli, M Burlando, G Stinco, G Girolomoni, ...
British Journal of Dermatology 181 (2), 413-414, 2019
272019
Dupilumab treatment in children aged 6–11 years with atopic dermatitis: a multicentre, real-life study
M Napolitano, G Fabbrocini, I Neri, L Stingeni, V Boccaletti, V Piccolo, ...
Pediatric Drugs 24 (6), 671-678, 2022
262022
Moderate‐to‐severe atopic dermatitis in adolescents treated with dupilumab: a multicentre Italian real‐world experience
L Stingeni, L Bianchi, E Antonelli, ES Caroppo, SM Ferrucci, M Ortoncelli, ...
Journal of the European Academy of Dermatology and Venereology 36 (8), 1292-1299, 2022
262022
Real‐life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: a 104‐week multicenter retrospective study–IL PSO …
L Gargiulo, L Ibba, P Malagoli, RG Angileri, F Bardazzi, N Bernardini, ...
Journal of the European Academy of Dermatology and Venereology 37 (5), 1017-1027, 2023
212023
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20